Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 2, 2009
Patent Application Number
10672278
Date Filed
September 29, 2003
Patent Primary Examiner
Patent abstract
The present invention provides humanized, chimeric and human MN3 antibodies, fusion proteins, and fragments thereof. The antibodies, fusion proteins, and fragments thereof, as well as combinations with other suitable antibodies, are useful for the treatment and diagnosis of granulocyte related disorders and diseases, such as leukemia.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
